New Market Research Report: DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2013 Update

Boston, MA -- (SBWIRE) -- 01/21/2014 -- DexCom, Inc. (DexCom) is a medical device company. The company operates in the design, development and selling of continuous glucose monitoring systems for ambulatory. It gained support for its third generation system, the SEVEN PLUS, from the US Food and Drug Administration (FDA). DexCom's products are for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company's membrane technology has several polymer layers organized for selective permit for the appropriate mix of oxygen and glucose to move through the membrane and react with a glucose specific enzyme. Its ambulatory glucose examining systems use radiofrequency telemetry for wireless broadcast information from the transmitter in a pod atop the sensor till receiver. DexCom small handheld receiver is carried by the patient and wirelessly receives continuous glucose values from the sensor. DexCom is headquartered in San Diego, California, the US.